
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-05-21 15:00:54Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. This development coincides with a sustained rally in the stock price, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.
Read More
Max Healthcare Sees Sharp Open Interest Surge Amid Strong Price Momentum
2026-05-21 14:00:36Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This increase accompanies a robust price rally, with the stock outperforming its sector and sustaining gains over the past week, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.
Read More
Max Healthcare Institute Ltd Sees Significant Open Interest Surge Amid Strong Price Momentum
2026-05-21 13:00:30Max Healthcare Institute Ltd has witnessed a notable 19.22% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This increase accompanies a robust price rally, with the stock outperforming its sector and sustaining gains over the past week, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.
Read More
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Strong Market Momentum
2026-05-21 12:00:22Max Healthcare Institute Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock has outperformed its sector peers, supported by rising volumes and sustained investor interest, despite a recent downgrade in its Mojo Grade to Sell.
Read More
Max Healthcare Sees Sharp Open Interest Surge Amid Strong Derivatives Activity
2026-05-21 11:00:16Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This increase accompanies a sustained rally in the stock price, reflecting growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.
Read MoreP/E at 71.79 vs Industry's 62.99: What the Data Shows for Max Healthcare Institute Ltd
2026-05-21 09:21:39Valuation Picture: Premium P/E in a Competitive Sector The hospital sector, characterised by steady demand and evolving healthcare needs, currently trades at an average P/E of 62.99. Against this backdrop, Max Healthcare Institute Ltd commands a P/E of 71.79, a premium of approximately 14% over its industry peers. This elevated valuation suggests that investors are pricing in expectations of superior earnings growth or operational resilience relative to the sector. However, the premium also raises questions about whether the stock’s price adequately reflects underlying fundamentals or if it is vulnerable to a correction should growth disappoint. ...
Read MoreP/E at 70.94 vs Industry's 62.71: What the Data Shows for Max Healthcare Institute Ltd
2026-05-20 09:21:22Valuation Picture: Premium Pricing in a Competitive Sector The current P/E of Max Healthcare Institute Ltd stands at 70.94, which is approximately 13.2% higher than the hospital industry average of 62.71. This premium valuation suggests that the market is pricing in expectations of superior earnings growth or operational performance relative to peers. However, the stock’s recent returns do not fully justify this elevated multiple, raising questions about the sustainability of such a premium — previously rated Hold, what is Max Healthcare’s current rating? Inv...
Read MoreP/E at 70.7 vs Industry's 62.4: What the Data Shows for Max Healthcare Institute Ltd
2026-05-19 09:21:02Significance of Nifty 50 Membership Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Max Healthcare Institute Ltd. This membership ensures the stock is a key component in numerous passive and active funds tracking the benchmark, thereby influencing demand dynamics. The company’s market capitalisation of ₹1,03,134.64 crores firmly establishes it as a large-cap entity, reinforcing its role as a bellwether within the hospital sector. Index inclusion often leads to enhanced institutional interest, as fund managers align portfolios with benchmark constituents. However, this also subjects the stock to heightened scrutiny regarding financial performance and valuation. Max Healthcare’s c...
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08-Aug-2026 | Source : BSESchedule of Earnings Call for Investors and Analysts
Board Meeting Intimation for Consideration And Approval Of Financial Results
08-Aug-2026 | Source : BSEMax Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
07-Aug-2026 | Source : BSEDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Corporate Actions
13 Aug 2026
Max Healthcare Institute Ltd has declared 20% dividend, ex-date: 03 Jul 26
No Splits history available
No Bonus history available
No Rights history available